Vitaspring Biomedical (VSBC) Cash & Equivalents (2017 - 2026)
Vitaspring Biomedical (VSBC) posted Cash & Equivalents of $13,367 for fiscal Q2 2027 (quarter ended Jul 31, 2026), compared with $799.00 a year earlier and up 63.7% from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Jan 31, 2026), Vitaspring Biomedical's Cash & Equivalents came in at $2,084, up 666.2% from FY2025.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -46.0% (FY2021 to FY2026).
- In prior fiscal years, Vitaspring Biomedical's Cash & Equivalents was $272.00 in FY2025, $13.00 in FY2024 (-100.0%), $29,656 in FY2023 (-72.3%) and $107,212 in FY2022 (+136.2%).
- The fiscal Q2 2027 figure stands as the highest quarterly Cash & Equivalents since fiscal Q4 2023.
- On a year-over-year basis, Cash & Equivalents increased in 1 of the last four quarters, with growth averaging 138.5%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was fiscal Q4 2026, with growth of 666.2%; the weakest was fiscal Q4 2024, with a decline of 100.0%.
- According to Business Quant data, Cash & Equivalents for the three prior fiscal quarters was $8,167 (Q1 2027), $2,084 (Q4 2026) and $1,960 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Vitaspring Biomedical | 4.14 Mn | 4.12 Mn | - | 13,367.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 13,367.00 |
| Apr 30, 2026 | 8,167.00 |
| Jan 31, 2026 | 2,084.00 |
| Oct 31, 2025 | 1,960.00 |
| Jul 31, 2025 | 799.00 |
| Jan 31, 2025 | 272.00 |
| Oct 31, 2024 | 2,062.00 |
| Jul 31, 2024 | 5,525.00 |
| Apr 30, 2024 | 968.00 |
| Jan 31, 2024 | 13.00 |
| Oct 31, 2023 | 2,636.00 |
| Jul 31, 2023 | 7,181.00 |
| Apr 30, 2023 | 2,993.00 |
| Jan 31, 2023 | 29,656.00 |
| Oct 31, 2022 | 24,050.00 |
| Jul 31, 2022 | 21,590.00 |
| Apr 30, 2022 | 79,151.00 |
| Jan 31, 2022 | 107,212.00 |
| Oct 31, 2021 | 214,057.00 |
| Jul 31, 2021 | 614,063.00 |
API Access
Vitaspring Biomedical Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();